Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Gilbert J. L'Italien, ScD
JCP
Original Research
A Multicenter, Randomized, Double-Blind Study of the Effects of Aripiprazole in Overweight Subjects With Schizophrenia or Schizoaffective Disorder Switched From Olanzapine
July 31, 2008
John W. Newcomer
,
Joao Alberto Campos
,
Ronald N. Marcus
, et al
JCP
Original Research
Predicted Risk of Diabetes and Coronary Heart Disease in Patients With Schizophrenia: Aripiprazole Versus Standard of Care
May 11, 2008
Lawrence Blonde
,
Hong J. Kan
,
Elane M. Gutterman
, et al
JCP
Original Research
Comparison of Metabolic Syndrome Incidence Among Schizophrenia Patients Treated With Aripiprazole Versus Olanzapine or Placebo
October 15, 2007
Gilbert J. L'Italien
,
Daniel E. Casey
,
Hong J. Kan
, et al
JCP
Original Research
Risk of Diabetes Mellitus Associated With Atypical Antipsychotic Use Among Patients With Bipolar Disorder: A Retrospective, Population-Based, Case-Control Study
July 14, 2006
Jeff J. Guo
,
Patricia K. Corey-Lisle
,
Hong Li
, et al
